2016

11101 bookmarks
Newest
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in
·x.com·
William Makis MD on X: "NEW ARTICLE: IVERMECTIN and FENBENDAZOLE Testimonial - 78 year old Nebraska PARKINSON'S DISEASE patient of 8 years, cured after 4 months! My best Parkinson's Disease & Ivermectin testimonial yet! 😃 77 year old Nebraska Parkinson's Disease patient of 8 years We started in https://t.co/p7qtTiDRTC" / X
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
Gut microbiome alterations are linked to various diseases, including neurodegeneration, but their ecological and functional impacts remain unclear. Using integrated multi-omics (metagenomics and metatranscriptomics), we analyse microbiome gene co-expression networks in Parkinson's disease (PD) and h …
·pubmed.ncbi.nlm.nih.gov·
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's disease - PubMed
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
Researchers are increasingly focusing on understanding the microbiota’s influence on disease susceptibility and overall health. The vast number of microorganisms in our gastrointestinal tract and their extensive surface area underscore their ...
·pmc.ncbi.nlm.nih.gov·
The Small Intestinal Microbiota and the Gut–Brain Axis in Parkinson’s Disease: A Narrative Review - PMC
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease - PMC
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease - PMC
The biomarkers of Parkinson’s disease (PD) remain to be investigated. This work aimed to identify blood biomarkers for PD using targeted metabolomics analysis. We quantified the plasma levels of 255 metabolites in 92 PD patients and 60 healthy ...
·pmc.ncbi.nlm.nih.gov·
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease - PMC
DMSO Mixtures Transform Natural Medicine
DMSO Mixtures Transform Natural Medicine
Numerous natural therapies, when combined with DMSO, are able to both rejuvenate the body and treat a variety of complex and challenging illnesses.
·midwesterndoctor.com·
DMSO Mixtures Transform Natural Medicine